Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AccuMed (US) takes over Sensititre (UK):

This article was originally published in Clinica

Executive Summary

Laboratory diagnostic products company AccuMed (US) has purchased Sensititre (UK) and its US assets and operations from Radiometer (Denmark) for an undisclosed amount. Blood gas metre manufacturer Radiometer has wanted to leave the microbiology market for some time and has in the past said it hopes to end up with an extraordinary pre-tax income for the Sensititre operations of $1-2.5 million (see Clinica No 635, p 17). Sensititre produces antimicrobial susceptibility and bacterial identification testing systems based on its microplate technology. It will become part of AccuMed's Microbiology Division which will be headed by Tony DiFranco, formerly Sensititre's vice-president of US operations. AccuMed is a privately-held company in Chicago with annual sales in excess of $5 million.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts